Federated Hermes’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.66K Buy
+119
New +$1.66K ﹤0.01% 1969
2023
Q2
Sell
-77,342
Closed -$1.97M 2230
2023
Q1
$1.97M Buy
77,342
+56,507
+271% +$1.44M 0.01% 961
2022
Q4
$609K Buy
+20,835
New +$609K ﹤0.01% 1300
2020
Q2
Sell
-92
Closed -$1K 2383
2020
Q1
$1K Buy
+92
New +$1K ﹤0.01% 2159